Application 217830
- Type
- ANDA
- Sponsor
- MACLEODS PHARMACEUTICALS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | ABACAVIR, DOLUTEGRAVIR AND LAMIVUDINE | ABACAVIR, DOLUTEGRAVIR, LAMIVUDINE | TABLET | 5MG | No | No |
| 003 | ABACAVIR, DOLUTEGRAVIR AND LAMIVUDINE | ABACAVIR, DOLUTEGRAVIR, LAMIVUDINE | TABLET | 30MG | No | No |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.